Currently out of the existing stock ratings of William Tanner, 8 are a HOLD (27.59%), 20 are a BUY (68.97%), 1 are a SELL (3.45%).

William Tanner

Work Performance Price Targets & Ratings Chart

Analyst William Tanner works with a stock forecast success ratio of 35.4% fulfilled within 249.17 days on average.

William Tanner’s has documented 59 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on NVAX, Novavax at 15-Jun-2021.

Wall Street Analyst William Tanner

Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 7/7/2020. The price target of $148 was fulfilled within 21 days with a profit of $43.44 (41.55%) receiving and performance score of 19.78.

Average potential price target upside

NVAX Novavax AIMT Aimmune Therapeutics ALKS Alkermes Plc JAZZ Jazz Pharmaceuticals PLC PRTA Prothena plc TXMD TherapeuticsMD

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

19

$14.57 (328.89%)

35

1 months 21 days ago

13/20 (65%)

$13.61 (252.50%)

176

Buy

12

$7.57 (170.88%)

15

5 months 12 days ago

14/37 (37.84%)

$5.76 (92.31%)

64

Hold

10

$5.57 (125.73%)

110

1 years 2 days ago

0/6 (0%)

$1.77 (21.51%)

Sell

13

$8.57 (193.45%)

16

1 years 4 months 7 days ago

2/3 (66.67%)

$1.68 (14.84%)

85

Sell

27

$22.57 (509.48%)

209

1 years 7 months ago

5/7 (71.43%)

$4.56 (20.32%)

46

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by William Tanner?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?